What they were paid
Tango Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $79,375 | $21,938 | $90,638 | $0 | $191,951 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tango Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001193125-26-160287, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Tango Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themCompensation (Chair)
The rest of the Tango Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Barbara Weber, M.D | Director | $0 |
| John Ketchum | Independent Director | $196,139 |
| Kanishka Pothula | Independent Director | $0 |
| Lesley Ann Calhoun | Independent Director | $176,326 |
| Mace Rothenberg, M.D | Independent Director | $169,701 |
| Malte Peters, M.D | Director | $1,151,381 |
| Sung Lee | Independent Director | $0 |
The full Tango Therapeutics compensation record
free company briefThis page is one director within Tango Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat